Effectiveness of COVID-19 vaccination in patients after allogeneic haematopoietic cell transplant: how much protection are we getting?

Sengsayadeth, Salyka; Broglie, Larisa; Savani, Bipin N

Sengsayadeth, Salyka; Broglie, Larisa; Savani, Bipin N.

Afiliação

Sengsayadeth S; Section of Hematology and Stem Cell Transplant, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
Broglie L; Department of Pediatrics, Division of Hematology/Oncology/Blood and Marrow Transplantation, Medical College of Wisconsin, Milwaukee, WI, USA.
Savani BN; Section of Hematology and Stem Cell Transplant, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.

Br J Haematol ; 196(4): 809-811, 2022 02.

Article em En | MEDLINE | ID: mdl-34850381

Assuntos

COVID-19; Transplante de Células-Tronco Hematopoéticas; Vacinas contra COVID-19; Humanos; SARS-CoV-2; Vacinação

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / COVID-19 Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google